CLX-0921

N/A

Report date: 2022/06/27 20:00:35
NME

Base Information

Drug NameCLX-0921
Drug Alias NameTHR-0921CLX-0921
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionPeroxisome proliferator-activated receptor γ agonists
TargetsPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsDiabetes Mellitus, Type 2Arthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesTheracos Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheracos IncBailu Pharmaceutical Technology (Shanghai) Co LtdPatheon Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Arthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksDrugBank